673 related articles for article (PubMed ID: 30073676)
1. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
2. Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.
Porter LH; Lawrence MG; Wang H; Clark AK; Bakshi A; Obinata D; Goode D; Papargiris M; Mural ; Clouston D; Ryan A; Norden S; Corey E; Nelson PS; Isaacs JT; Grummet J; Kourambas J; Sandhu S; Murphy DG; Pook D; Frydenberg M; Taylor RA; Risbridger GP
Prostate; 2019 Aug; 79(11):1326-1337. PubMed ID: 31212368
[TBL] [Abstract][Full Text] [Related]
3. Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.
Lawrence MG; Pook DW; Wang H; Porter LH; Frydenberg M; Kourambas J; Appu S; Poole C; Beardsley EK; Ryan A; Norden S; Papargiris MM; Risbridger GP; Taylor RA
Prostate; 2015 Sep; 75(13):1475-83. PubMed ID: 26177841
[TBL] [Abstract][Full Text] [Related]
4. Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development.
Philp LK
Methods Mol Biol; 2024; 2806():153-185. PubMed ID: 38676802
[TBL] [Abstract][Full Text] [Related]
5. An original patient-derived xenograft of prostate cancer with cyst formation.
Yoshikawa T; Kobori G; Goto T; Akamatsu S; Terada N; Kobayashi T; Tanaka Y; Jung G; Kamba T; Ogawa O; Inoue T
Prostate; 2016 Aug; 76(11):994-1003. PubMed ID: 27098584
[TBL] [Abstract][Full Text] [Related]
6. The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.
Palanisamy N; Yang J; Shepherd PDA; Li-Ning-Tapia EM; Labanca E; Manyam GC; Ravoori MK; Kundra V; Araujo JC; Efstathiou E; Pisters LL; Wan X; Wang X; Vazquez ES; Aparicio AM; Carskadon SL; Tomlins SA; Kunju LP; Chinnaiyan AM; Broom BM; Logothetis CJ; Troncoso P; Navone NM
Clin Cancer Res; 2020 Sep; 26(18):4933-4946. PubMed ID: 32576626
[TBL] [Abstract][Full Text] [Related]
7. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy.
Pan CX; Zhang H; Tepper CG; Lin TY; Davis RR; Keck J; Ghosh PM; Gill P; Airhart S; Bult C; Gandara DR; Liu E; de Vere White RW
PLoS One; 2015; 10(8):e0134346. PubMed ID: 26270481
[TBL] [Abstract][Full Text] [Related]
8. Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts.
Thomas PB; Alinezhad S; Joshi A; Sweeney K; Tse BWC; Tevz G; McPherson S; Nelson CC; Williams ED; Vela I
Curr Oncol; 2023 Oct; 30(11):9437-9447. PubMed ID: 37999103
[TBL] [Abstract][Full Text] [Related]
9. Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.
Heo EJ; Cho YJ; Cho WC; Hong JE; Jeon HK; Oh DY; Choi YL; Song SY; Choi JJ; Bae DS; Lee YY; Choi CH; Kim TJ; Park WY; Kim BG; Lee JW
Cancer Res Treat; 2017 Oct; 49(4):915-926. PubMed ID: 28052650
[TBL] [Abstract][Full Text] [Related]
10. LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.
Nguyen HM; Vessella RL; Morrissey C; Brown LG; Coleman IM; Higano CS; Mostaghel EA; Zhang X; True LD; Lam HM; Roudier M; Lange PH; Nelson PS; Corey E
Prostate; 2017 May; 77(6):654-671. PubMed ID: 28156002
[TBL] [Abstract][Full Text] [Related]
11. Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
Yu J; Qin B; Moyer AM; Sinnwell JP; Thompson KJ; Copland JA; Marlow LA; Miller JL; Yin P; Gao B; Minter-Dykhouse K; Tang X; McLaughlin SA; Moreno-Aspitia A; Schweitzer A; Lu Y; Hubbard J; Northfelt DW; Gray RJ; Hunt K; Conners AL; Suman VJ; Kalari KR; Ingle JN; Lou Z; Visscher DW; Weinshilboum R; Boughey JC; Goetz MP; Wang L
Breast Cancer Res; 2017 Dec; 19(1):130. PubMed ID: 29212525
[TBL] [Abstract][Full Text] [Related]
12. Subrenal capsule grafting technology in human cancer modeling and translational cancer research.
Wang Y; Wang JX; Xue H; Lin D; Dong X; Gout PW; Gao X; Pang J
Differentiation; 2016; 91(4-5):15-9. PubMed ID: 26547391
[TBL] [Abstract][Full Text] [Related]
13. The what, when, and why of human prostate cancer xenografts.
Brennen WN; Isaacs JT
Prostate; 2018 Jun; 78(9):646-654. PubMed ID: 29575112
[TBL] [Abstract][Full Text] [Related]
14. The future of patient-derived xenografts in prostate cancer research.
Lawrence MG; Taylor RA; Cuffe GB; Ang LS; Clark AK; Goode DL; Porter LH; Le Magnen C; Navone NM; Schalken JA; Wang Y; van Weerden WM; Corey E; Isaacs JT; Nelson PS; Risbridger GP
Nat Rev Urol; 2023 Jun; 20(6):371-384. PubMed ID: 36650259
[TBL] [Abstract][Full Text] [Related]
15. Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.
Anselmino N; Labanca E; Shepherd PDA; Dong J; Yang J; Song X; Nandakumar S; Kundra R; Lee C; Schultz N; Zhang J; Araujo JC; Aparicio AM; Subudhi SK; Corn PG; Pisters LL; Ward JF; Davis JW; Vazquez ES; Gueron G; Logothetis CJ; Futreal A; Troncoso P; Chen Y; Navone NM
Clin Cancer Res; 2024 May; 30(10):2272-2285. PubMed ID: 38488813
[TBL] [Abstract][Full Text] [Related]
16. Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer.
Lange T; Oh-Hohenhorst SJ; Joosse SA; Pantel K; Hahn O; Gosau T; Dyshlovoy SA; Wellbrock J; Feldhaus S; Maar H; Gehrcke R; Kluth M; Simon R; Schlomm T; Huland H; Schumacher U
Sci Rep; 2018 Dec; 8(1):17535. PubMed ID: 30510249
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity.
Chen X; Shen C; Wei Z; Zhang R; Wang Y; Jiang L; Chen K; Qiu S; Zhang Y; Zhang T; Chen B; Xu Y; Feng Q; Huang J; Zhong Z; Li H; Che G; Xiao K
Cancer Biol Med; 2021 Feb; 18(1):184-198. PubMed ID: 33628593
[TBL] [Abstract][Full Text] [Related]
18. Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer.
Valta MP; Zhao H; Saar M; Tuomela J; Nolley R; Linxweiler J; Sandholm J; Lehtimäki J; Härkönen P; Coleman I; Nelson PS; Corey E; Peehl DM
Clin Exp Metastasis; 2016 Apr; 33(4):325-37. PubMed ID: 26873136
[TBL] [Abstract][Full Text] [Related]
19. Establishment and preclinical application of a patient-derived xenograft model for uterine cancer.
Jeong SY; Cho YJ; Ryu JY; Choi JJ; Hwang JR; Kim B; Lee YY; Kim HS; Lee JW
Gynecol Oncol; 2021 Jul; 162(1):173-181. PubMed ID: 33972086
[TBL] [Abstract][Full Text] [Related]
20. Establishing prostate cancer patient derived xenografts: lessons learned from older studies.
Russell PJ; Russell P; Rudduck C; Tse BW; Williams ED; Raghavan D
Prostate; 2015 May; 75(6):628-36. PubMed ID: 25560784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
